Trump receives experimental antibody treatment for Covid-19 diagnosis

President Donald Trump has received an experimental drug following his diagnosis of Covid-19, the White House said Friday.

“As a precautionary measure, he received a single 8 gram dose of Regeneron’s polyclonal antibody cocktail. He completed the infusion without incident,” Dr. Sean Conley, the president’s physician, wrote in a memorandum.

Full coverage of the coronavirus outbreak

The drug cocktail is a combination of two so-called monoclonal antibodies. The treatment is meant to provide the body’s immune system with a temporary, but immediate, boost to fight off the coronavirus.

Monoclonal antibodies (or, in this case, polyclonal because there are two in the cocktail) are made in a lab to mimic the body’s natural antibodies. Antibodies act by recognizing specific germs — in this case, SARS-CoV-2, the virus that causes Covid-19 — and harnessing the immune system to fight them off.

vCard QR Code

vCard.red is a free platform for creating a mobile-friendly digital business cards. You can easily create a vCard and generate a QR code for it, allowing others to scan and save your contact details instantly.

The platform allows you to display contact information, social media links, services, and products all in one shareable link. Optional features include appointment scheduling, WhatsApp-based storefronts, media galleries, and custom design options.

The therapy, though still unproven, is considered by experts to be one of the most promising treatment options for the illness.

Regeneron confirmed it provided its drug to the president under what is called “compassionate use,” through which the Food and Drug Administration allows access to experimental drugs outside of clinical trials for patients with a life-threatening condition or serious disease.

Download the NBC News app for full coverage of the coronavirus outbreak

The treatment is currently being studied in clinical trials as a potential treatment and possible prevention of illness in people who have been exposed. The drug company said Tuesday that early evidence from the trials suggest the treatment appears to be beneficial in patients with mild to moderate illness.

“It decreased viral load, and made symptoms resolve faster,” Dr. Todd Rice, an associate professor of medicine at Vanderbilt University Medical Center in Nashville, Tennessee, said. Rice is not involved with Regeneron’s clinical trials.

Trump is said to have mild symptoms, including fatigue and a low-grade fever. As a precautionary measure, the president has been taken to Walter Reed National Military Medical Center.

The letter from the president’s physician also said Trump has been taking zinc, vitamin D, the heartburn drug famotidine, a daily aspirin and a sleep aid called melatonin. All of those are sold over the counter. There is no solid evidence any might help treat Covid-19.

Follow NBC HEALTH on Twitter & Facebook.

source: nbcnews.com


🕐 Top News in the Last Hour By Importance Score

# Title 📊 i-Score
1 Louisiana, Missouri and Virginia report first measles cases of 2025 🔴 78 / 100
2 How UK steel can rise from the ashes: Climate levies set to raise £9bn for Treasury under scrutiny 🔴 75 / 100
3 Popular Easter treat could be LETHAL to dogs, vets warn – and it's not chocolate 🔴 65 / 100
4 Two killed in Israeli attacks in southern Lebanon 🔴 65 / 100
5 Jim Davidson opens up about his cocaine addiction 'Columbia could not produce enough' 🔵 45 / 100
6 Crisis in Majorca as hundreds of squatters occupy homes 🔵 45 / 100
7 St Johnstone 0-5 Celtic: Saints are like rabbits in the headlights while Bhoys stay on course for the Treble as Maeda leads demolition job at Hampden 🔵 35 / 100
8 This Sherlock Holmes Adventure Game Is A Deeply Beautiful Love Story 🔵 35 / 100
9 Meghan's having a quacking Easter! Duchess of Sussex is surprised by a flock of unexpected guests near her Montecito mansion 🔵 32 / 100
10 Amelia Dimoldenberg Gives Update on Andrew Garfield: ‘Great Dynamic’ 🔵 30 / 100

View More Top News ➡️